TS
Teguh Haryo Sasongko
IMU University, Perubatan Siswazah Universiti Perdana, Kobe University, Universitas Gadjah Mada Fakultas Kedokteran, Universiti Perdana
Research areas: Medicine · Genetics · Genomics and Rare Diseases · Neurogenetic and Muscular Disorders Research · Muscle Physiology and Disorders
0000-0002-6226-6264
Employment
-
International Medical University Associate Professor2022 - Present
-
Perubatan Siswazah Universiti Perdana Associate Professor2022 - 2022
-
Universiti Perdana Associate Professor, Royal College of Surgeon in Ireland (RCSI) School of Medicine2018 - 2021
-
International Medical University Associate Professor2017 - 2018
-
Universiti Sains Malaysia - Kampus Kesihatan Senior Lecturer2009 - 2016
Education
-
Kobe University PhD2003 - 2008
-
Universitas Gadjah Mada Fakultas Kedokteran Medical Doctor (MD)1996 - 2003
Projects & Funding
-
Bridging Global Disparities: Exploring Ethical Dimensions of Rare Inherited Disease Research Priority Setting in Low- and Middle-Income Countries Global Forum on Bioethics in Research (WHO-NIH)2025 - 2026
-
Unveiling the Molecular Epidemiology of Dengue Infection in underreported region; A Systematic Literature Review of South-East-Asian countries Merck Sharp & Dohme2024 - 2025
-
Surveillance System to observe seroconversion to SARS-CoV-2 in Human: Combining Hospital Based and Population Based Longitudinal Study in Sleman HDSS (Health and Demographic Surveillance System) Ministry of Education, Research, Technology, and Higher Education, Republic of Indonesia2021 - 2024
-
Development of AI-powered Clinical Decision-Support System based on Big-Data Analytics for Molecular Genetic Diagnosis Ministry of Higher Education2019 - 2022
-
Elucidating the regulatory effect of miRNA on survival motor neuron (SMN) protein in spinal muscular atropy (SMA) Human iPSC-Derived Fibroblast Ministry of Higher Education2019 - 2022
-
Genetic Host Susceptibility Factors to Severe Dengue Infection – A Systematic Review International Medical University2018 - 2018
-
Cell-Based Bioassays and Virtual Molecular Docking for Elucidating The Effects Of Malaysian-Derived mTOR Inhibitor Substances On A Tuberous On A Tuberous-Sclerosis-Complex-Derived Tumor Cells Universiti Sains Malaysia2014 - 2017
Publications (49)
- Rare diseases are an overlooked dimension in climate–health adaptation Save
- The ASEAN genome consortium: advancing equitable precision medicine through regional solidarity Save
- Roles of microRNAs in thalassemia: Mechanisms, biomarkers, and therapeutic implications – a narrative review Save
- Potential Use of MicroRNA Technology in Thalassemia Therapy Save
- Genetic Background of β Thalassemia Modifier: Recent Update Save
- Antiphospholipid antibodies in epilepsy: A systematic review and meta-analysis Save
- A 15-year single centre retrospective study of antiphospholipid syndrome patients from Northern Malaysia Save
- Combination of Multiple Ligation-Dependent Probe Amplification and Illumina MiSeq Amplicon Sequencing for TSC1/TSC2 Gene Analyses in Patients with Tuberous Sclerosis Complex Save
- Placebo controlled trials: Interests of subjects versus interests of drug regulators Save
- Presence of anticardiolipin antibodies in patients with dementia: A systematic review and meta-analysis Save
- Social and communicative functions of informed consent forms in East Asia and beyond Save
- Therapeutic suppression of nonsense mutation: An emerging target in multiple diseases and thrombotic disorders Save
- Antiphospholipid antibody-mediated thrombotic mechanisms in antiphospholipid syndrome: Towards pathophysiology-based treatment Save
- Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome Save
- DNA methylation: An epigenetic insight into type 2 diabetes mellitus Save
- Natural products towards the discovery of potential future antithrombotic drugs Save
- Rapamycin and rapalogs for tuberous sclerosis complex Save
- Transcript, methylation and molecular docking analyses of the effects of HDAC inhibitors, SAHA and Dacinostat, on SMN2 expression in fibroblasts of SMA patients Save
- Type 2 diabetes mellitus and Alzheimer’s disease: Bridging the pathophysiology and management Save
- ‘Non-criteria’ neurologic manifestations of antiphospholipid syndrome: A hidden kingdom to be discovered Save